Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
About the study The current study performed a randomized, double-blind, crossover trial at the Research Institute of the McGill University Health Centre in Montreal, Quebec, Canada, to investigate whether semaglutide improved glycemic control and other nonglycemic outcomes in patients with T1D and using AID
Competing interests DB received presentation fees (TEVA, Novartis and Pfizer), travel fees (Allergan, TEVA, Pfizer, Abbvie and Lundbeck), advisory board fees (Novartis, Lilly, Teva, Lundbeck, Pfizer and Abbvie) and participated in clinical trials (TEVA, Lundbeck, Novartis, Lilly and Novo Nordisk Foundation) outside of the submitted work
But nearly four in 10 (38%) say they took the drugs solely to lose weight
Retatrutide is a new weight loss treatment currently being tested in clinical trials
Medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), which mimics both GLP-1 and GIP, are synthetic versions of these hormones
US$ 29.40
US$ 29.30
US$ 23.96
